Table 3 Association of comorbid conditions with the EQ-5D index scores stratified for COPD cases and control subjects
EQ-5D utility score | EQ-5D valuation score | |||
|---|---|---|---|---|
Covariate | COPD cases | Control subjects | COPD cases | Control subjects |
Diabetes | −0.03 [-0.05 to -0.00] | −0.03 [-0.05 to -0.02] | −0.01 [-0.03 to 0.01] | −0.03 [-0.05 to -0.02] |
Stroke | −0.04 [-0.08 to 0.00] | −0.05 [-0.08 to -0.03] | −0.03 [-0.06 to 0.00] | −0.06 [-0.08 to -0.04] |
Myocardial infarction | −0.05 [-0.08 to -0.02] | −0.02 [-0.04 to -0.00] | −0.05 [-0.07 to -0.02] | −0.03 [-0.05 to -0.01] |
Cancer | −0.03 [-0.05 to -0.00] | −0.02 [-0.03 to -0.00] | −0.02 [-0.04 to 0.00] | −0.03 [-0.04 to -0.01] |
Arthritis | −0.09 [-0.12 to -0.06] | −0.08 [-0.09 to -0.06] | −0.07 [-0.10 to -0.05] | −0.08 [-0.09 to -0.06] |
Obesity (BMI ≥ 30) | −0.06 [-0.08 to -0.04] | −0.04 [-0.05 to -0.03] | −0.04 [-0.06 to -0.02] | −0.04 [-0.05 to -0.05] |